Nancy Wyzga

873 total citations
16 papers, 673 citations indexed

About

Nancy Wyzga is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Nancy Wyzga has authored 16 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Nancy Wyzga's work include Inflammatory Bowel Disease (13 papers), Bone Metabolism and Diseases (5 papers) and Microscopic Colitis (5 papers). Nancy Wyzga is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Bone Metabolism and Diseases (5 papers) and Microscopic Colitis (5 papers). Nancy Wyzga collaborates with scholars based in United States and Canada. Nancy Wyzga's co-authors include Jeffrey S. Hyams, Francisco Sylvester, Donald L. Kreutzer, William R. Treem, Gloria Gronowicz, John E. Fitzgerald, Anne M. Griffiths, Christopher J. Justinich, Trudy Lerer and Patricia M. Davis and has published in prestigious journals such as Gastroenterology, Journal of Bone and Mineral Research and The Journal of Pediatrics.

In The Last Decade

Nancy Wyzga

15 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Wyzga United States 11 398 275 188 131 124 16 673
Tom Rohan Canada 11 106 0.3× 275 1.0× 177 0.9× 166 1.3× 39 0.3× 12 851
Kamila Stawczyk‐Eder Poland 13 274 0.7× 170 0.6× 71 0.4× 127 1.0× 73 0.6× 40 396
M Huorka Slovakia 11 170 0.4× 194 0.7× 69 0.4× 141 1.1× 61 0.5× 34 433
E Aganna United Kingdom 6 125 0.3× 100 0.4× 124 0.7× 66 0.5× 114 0.9× 7 446
Wei‐Yih Chiu Taiwan 15 91 0.2× 134 0.5× 176 0.9× 84 0.6× 47 0.4× 30 596
SJ Gallacher United Kingdom 11 62 0.2× 75 0.3× 124 0.7× 80 0.6× 30 0.2× 21 535
Lydia Kossiva Greece 13 100 0.3× 49 0.2× 168 0.9× 74 0.6× 48 0.4× 47 489
Erbil Doğan Türkiye 17 75 0.2× 50 0.2× 83 0.4× 117 0.9× 108 0.9× 49 875
Laura Winterfield United States 12 50 0.1× 331 1.2× 52 0.3× 93 0.7× 148 1.2× 18 686
Murray Cadzow New Zealand 14 107 0.3× 137 0.5× 166 0.9× 111 0.8× 16 0.1× 33 698

Countries citing papers authored by Nancy Wyzga

Since Specialization
Citations

This map shows the geographic impact of Nancy Wyzga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Wyzga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Wyzga more than expected).

Fields of papers citing papers by Nancy Wyzga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Wyzga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Wyzga. The network helps show where Nancy Wyzga may publish in the future.

Co-authorship network of co-authors of Nancy Wyzga

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Wyzga. A scholar is included among the top collaborators of Nancy Wyzga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Wyzga. Nancy Wyzga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Skinner, Anthony R., et al.. (2008). S1225 Fecal Osteoprotegerin: A Marker for Pediatric Ulcerative Colitis At Diagnosis - a Pilot Study. Gastroenterology. 134(4). A–205. 7 indexed citations
2.
Sylvester, Francisco, Patricia M. Davis, Nancy Wyzga, Jeffrey S. Hyams, & Trudy Lerer. (2006). Are activated T cells regulators of bone metabolism in children with Crohn disease?. The Journal of Pediatrics. 148(4). 461–466. 29 indexed citations
3.
Sylvester, Francisco, Nancy Wyzga, Jeffrey S. Hyams, et al.. (2006). Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflammatory Bowel Diseases. 13(1). 42–50. 129 indexed citations
4.
Wyzga, Nancy, Samuel Varghese, Stephen K. Wikel, Ernesto Canalis, & Francisco Sylvester. (2004). Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone. 35(3). 614–620. 28 indexed citations
5.
Varghese, Samuel, Nancy Wyzga, Anne M. Griffiths, & Francisco Sylvester. (2002). Effects of Serum From Children with Newly Diagnosed Crohn Disease on Primary Cultures of Rat Osteoblasts. Journal of Pediatric Gastroenterology and Nutrition. 35(5). 641–648. 42 indexed citations
6.
Varghese, Samuel, Nancy Wyzga, Anne M. Griffiths, & Francisco Sylvester. (2002). Effects of Serum From Children with Newly Diagnosed Crohn Disease on Primary Cultures of Rat Osteoblasts. Journal of Pediatric Gastroenterology and Nutrition. 35(5). 641–648. 4 indexed citations
7.
Sylvester, Francisco, Nancy Wyzga, Jeffrey S. Hyams, & Gloria Gronowicz. (2002). Effect of Crohn's Disease on Bone Metabolism In Vitro: A Role for Interleukin-6. Journal of Bone and Mineral Research. 17(4). 695–702. 91 indexed citations
8.
Hyams, Jeffrey S., Nancy Wyzga, Donald L. Kreutzer, Christopher J. Justinich, & Gloria Gronowicz. (1997). Alterations in Bone Metabolism in Children with Inflammatory Bowel Disease: An In Vitro Study. Journal of Pediatric Gastroenterology and Nutrition. 24(3). 289–295. 91 indexed citations
9.
Hyams, Jeffrey S., Nancy Wyzga, Donald L. Kreutzer, Christopher J. Justinich, & Gloria Gronowicz. (1997). Alterations in Bone Metabolism in Children with Inflammatory Bowel Disease: An In Vitro Study. Journal of Pediatric Gastroenterology and Nutrition. 24(3). 289–295. 3 indexed citations
10.
Hyams, Jeffrey S., John E. Fitzgerald, Nancy Wyzga, et al.. (1995). Relationship of Interleukin‐1 Receptor Antagonist to Mucosal Inflammation in Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 21(4). 419–425. 2 indexed citations
11.
Hyams, Jeffrey S., John E. Fitzgerald, Nancy Wyzga, et al.. (1995). Relationship of Interleukin-1 Receptor Antagonist to Mucosal Inflammation in Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 21(4). 419–425. 25 indexed citations
12.
Hyams, Jeffrey S., John E. Fitzgerald, Nancy Wyzga, et al.. (1994). Characterization of circulating interleukin-1 receptor antagonist expression in children with inflammatory bowel disease. Digestive Diseases and Sciences. 39(9). 1893–1899. 24 indexed citations
13.
Hyams, Jeffrey S., John E. Fitzgerald, William R. Treem, Nancy Wyzga, & Donald L. Kreutzer. (1993). Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology. 104(5). 1285–1292. 128 indexed citations
14.
Hyams, Jeffrey S., et al.. (1991). Tumor Necrosis Factor‐α Is Not Elevated in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 12(2). 233–236.
15.
Hyams, Jeffrey S., et al.. (1991). Tumor Necrosis Factor-α Is Not Elevated in Children with Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 12(2). 233–236. 54 indexed citations
16.
Hyams, Jeffrey S., William R. Treem, Dennis E. Carey, et al.. (1991). Comparison of collagen propeptides as growth markers in children with inflammatory bowel disease. Gastroenterology. 100(4). 971–975. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026